| Accession |
PRJCA017480 |
| Title |
Study of anaplastic lymphoma kinase-positive advanced non-small cell lung cancer |
| Relevance |
Medical |
| Data types |
Variation
|
| Organisms |
Homo sapiens
|
| Description |
Brigatinib in Patients with Anaplastic Lymphoma Kinase (ALK)-positive, Advanced Non-small Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib |
| Sample scope |
Monoisolate |
| Release date |
2023-06-05 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Sponsor
|
|
2018L03229/2018L03230/2018L03231
|
|
|
|
| Submitter |
ling
zhang (shfkgcp@163.com)
|
| Organization |
shanghai pulmonary hospital |
| Submission date |
2023-06-05 |
